Literature DB >> 6993700

Proteinuria during long-term captopril therapy.

D B Case, S A Atlas, J A Mouradian, R A Fishman, R L Sherman, J H Laragh.   

Abstract

Proteinuria developed in six of 81 hypertensive patients given captopril for at least four months (protein excretion, greater than 200 mg/24 hr). Two had previously elevated protein excretion. In all patients the increased protein excretion occurred by the fourth month of treatment. It subsided in four after two to nine months, despite continued therapy. In two of the four, proteinuria cleared completely within seven months after onset, while in the other two it subsided to the range of 600 mg/24 hr. However, in the remaining two patients proteinuria persisted during captopril therapy and was associated with hypoalbuminemia and hypercholesterolemia. Renal biopsy specimens showed mild membranous nephropathy in two patients, one of whom had a remittance of proteinuria during continued captopril treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6993700

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  19 in total

Review 1.  ACE inhibitors and proteinuria.

Authors:  R T Gansevoort; D de Zeeuw; P E de Jong
Journal:  Pharm World Sci       Date:  1996-12

Review 2.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

3.  Hypertension. Current therapeutic practice reviewed.

Authors:  B N Prichard
Journal:  Drugs       Date:  1986       Impact factor: 9.546

4.  How adverse drug reactions can play a role in innovative drug research.

Authors:  F Rikken; R Vos
Journal:  Pharm World Sci       Date:  1995-11-24

5.  Captopril in various forms of severe therapy-resistant hypertension.

Authors:  A Studer; T Lüscher; W Siegenthaler; W Vetter
Journal:  Klin Wochenschr       Date:  1981-01-15

6.  Long-term effect of captopril on kidney function in various forms of hypertension.

Authors:  W Vetter; M Wehling; E C Foerster; U Kuhlmann; H J Boerlin; P Greminger; H Vetter
Journal:  Klin Wochenschr       Date:  1984-08-01

7.  Captopril-associated lymphadenopathy.

Authors:  H Aberg; C Mörlin; G Frithz
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-14

8.  Effect of captopril on renal function in patients with congestive heart failure.

Authors:  G L Pierpont; G S Francis; J N Cohn
Journal:  Br Heart J       Date:  1981-11

Review 9.  Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney.

Authors:  G P Reams; J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

10.  Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition.

Authors:  Elena Velkoska; Rachael G Dean; Luke Burchill; Vicki Levidiotis; Louise M Burrell
Journal:  Clin Sci (Lond)       Date:  2010-02       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.